Orphan drug designation provides benefits such as tax credits, PDUFA fee waivers, and 7 years of market exclusivity upon approval. FDA designates MNV-201 as an orphan drug for myelodysplastic syndrome ...
In a city where cosmetic enhancement has become as common as a new haircut, Dr. Asif Pirani stands out not for radical ...
Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases ...
It is a big deal to choose to have facial surgery. Choosing a board-certified surgeon who specializes in the face and neck is the most important step. A full consultation will include a detailed talk ...
You don’t have to be a CEO, baby, to be in our show. The executives are great, but Arkansas Money & Politics readers recognize that it takes ...
After extensive research into the global cosmetic surgery landscape, we've curated a comprehensive guide to the world's ...
Often described as ‘miracle’ cells, stem cells need to be truly mastered if we’re to use them in medical treatments.
People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
The human brain can do many amazing things, but self-repair is not one of its repertoire of abilities. Once neurons die—from ...
News Medical on MSN
Stem cell therapy linked to lower risk of heart failure after a heart attack
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results